Table of Contents Author Guidelines Submit a Manuscript
Genetics Research International
Volume 2015, Article ID 820323, 5 pages
http://dx.doi.org/10.1155/2015/820323
Research Article

Genetic Variant in the CYP19A1 Gene Associated with Coronary Artery Disease

1Department of Genetics and Biotechnology, Faculty of Biology, University of Athens, 15784 Athens, Greece
2Department of Cardiology, General Hospital “KAT”, 14561 Athens, Greece

Received 26 November 2014; Revised 25 February 2015; Accepted 5 March 2015

Academic Editor: Francine Durocher

Copyright © 2015 Konstantina Bampali et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Lopez, C. Mathers, M. Ezzati et al., Global Burden of Disease and Risk Factors, World Health Organzation, 2008.
  2. A. S. Go, D. Mozaffarian, V. L. Roger et al., “Heart disease and stroke statistics—2013 update: a report from the American Heart Association,” Circulation, vol. 127, no. 1, pp. e6–e245, 2013. View at Publisher · View at Google Scholar
  3. G. D. Means, M. S. Mahendroo, C. J. Corbin et al., “Structural analysis of the gene encoding human aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis,” The Journal of Biological Chemistry, vol. 264, no. 32, pp. 19385–19391, 1989. View at Google Scholar · View at Scopus
  4. E. R. Simpson, C. Clyne, G. Rubin et al., “Aromatase—a brief overview,” Annual Review of Physiology, vol. 64, pp. 93–127, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. C. X. Ma, A. A. Adjei, O. E. Salavaggione et al., “Human aromatase: gene resequencing and functional genomics,” Cancer Research, vol. 65, no. 23, pp. 11071–11082, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Gennari, L. Masi, D. Merlotti et al., “A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism,” The Journal of Clinical Endocrinology & Metabolism, vol. 89, no. 6, pp. 2803–2810, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. I. M. Dick, A. Devine, and R. L. Prince, “Association of an aromatase TTTA repeat polymorphism with circulating estrogen, bone structure, and biochemistry in older women,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 288, no. 5, pp. E989–E995, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. C. A. Haiman, S. E. Hankinson, D. Spiegelman et al., “A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk,” International Journal of Cancer, vol. 87, no. 2, pp. 204–210, 2000. View at Publisher · View at Google Scholar
  9. I. Czajka-Oraniec and E. R. Simpson, “Aromatase research and its clinical significance,” Endokrynologia Polska, vol. 61, no. 1, pp. 126–134, 2010. View at Google Scholar · View at Scopus
  10. N. Harada, H. Sasano, H. Murakami, T. Ohkuma, H. Nagura, and Y. Takagi, “Localized expression of aromatase in human vascular tissues,” Circulation Research, vol. 84, no. 11, pp. 1285–1291, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Sasano, H. Murakami, S. Shizawa, S. Satomi, H. Nagura, and N. Harada, “Aromatase and sex steroid receptors in human vena cava,” Endocrine Journal, vol. 46, no. 2, pp. 233–242, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. A. L. Beitelshees, J. A. Johnson, M. L. Hames et al., “Aromatase gene polymorphisms are associated with survival among patients with cardiovascular disease in a sex-specific manner,” PloS ONE, vol. 5, no. 12, Article ID e15180, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. S. H. Olson, E. V. Bandera, and I. Orlow, “Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review,” American Journal of Epidemiology, vol. 165, no. 3, pp. 235–245, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Ramirez-Lorca, A. Grilo, M. T. Martinez-Larrad et al., “Sex and body mass index specific regulation of blood pressure by CYP19A1 gene variants,” Hypertension, vol. 50, no. 5, pp. 884–890, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Shimodaira, T. Nakayama, N. Sato et al., “Association study of aromatase gene (CYP19A1) in essential hypertension,” International Journal of Medical Sciences, vol. 5, no. 1, pp. 29–35, 2008. View at Google Scholar · View at Scopus
  16. S. A. Miller, D. D. Dykes, and H. F. Polesky, “A simple salting out procedure for extracting DNA from human nucleated cells,” Nucleic Acids Research, vol. 16, no. 3, p. 1215, 1988. View at Publisher · View at Google Scholar · View at Scopus
  17. S. S. Tworoger, J. Chubak, E. J. Aiello et al., “Association of cyp17, cyp19, cyp1b1 and comt polymorphisms with serum and urinary sex hormone concentration in post menopausal women,” Cancer Epidemiology Biomarkers and Prevention, vol. 13, no. 1, pp. 94–101, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. A. M. Dunning, M. Dowsett, C. S. Healey et al., “Polymorphisms associated with circulating sex hormone levels in postmenopausal women,” Journal of the National Cancer Institute, vol. 96, no. 12, pp. 936–945, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. F. De Castro, F. J. Moron, L. Montoro et al., “Polymprphisms associated with circulating sex hormone levels in postmenopausal women,” Journal of the National Cancer Institute, vol. 97, pp. 152–153, 2005. View at Google Scholar
  20. F. Baghaei, R. Rosmond, L. Westberg et al., “The CYP19 gene and associations with androgens and abdominal obesity in premenopausal women,” Obesity Research, vol. 11, no. 4, pp. 578–585, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Rappelli, “Hypertension and obesity after the menopause,” Journal of Hypertension, vol. 20, no. 2, pp. S26–S28, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. I. Lambrinoudaki, G. Christodoulakos, D. Rizos et al., “Endogenous sex hormones and risk factors atherosclerosis in healthy Greek postmenopausal women,” European Journal of Endocrinology, vol. 154, no. 6, pp. 907–916, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Akishita and J. Yu, “Hormonal effects on blood vessels,” Hypertension Research, vol. 35, no. 4, pp. 363–369, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Chen, A. Zeleniuch-Jacquotte, A. A. Arslan et al., “Endogenous hormones and coronary heart disease in postmenopausal women,” Atherosclerosis, vol. 216, no. 2, pp. 414–419, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Karim, H. N. Hodis, F. Z. Stanczyk, R. A. Lobo, and W. J. Mack, “Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women,” The Journal of Clinical Endocrinology & Metabolism, vol. 93, no. 1, pp. 131–138, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. T. A. Manolio, C. D. Furberg, L. Shemanski et al., “Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women,” Circulation, vol. 88, no. 5, pp. 2163–2171, 1993. View at Publisher · View at Google Scholar · View at Scopus
  27. S. H. Golden, A. Maguire, J. Ding et al., “Endogenous postmenopausal hormones and carotid atherosclerosis: a case-control study of the atherosclerosis risk in communities cohort,” The American Journal of Epidemiology, vol. 155, no. 5, pp. 437–445, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Kumagai, Y. Kai, and H. Sasaki, “Relationship between insulin resistance, sex hormones and sex hormone-binding globulin in the serum lipid and lipoprotein profiles of Japanese postmenopausal women,” Journal of Atherosclerosis and Thrombosis, vol. 8, no. 1, pp. 14–20, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. K. M. Rexrode, J. E. Manson, I.-M. Lee et al., “Sex hormone levels and risk of cardiovascular events in postmenopausal women,” Circulation, vol. 108, no. 14, pp. 1688–1693, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. G. P. Bernini, M. Sgro', A. Moretti et al., “Endogenous androgens and carotid intimal-medial thickness in women,” Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 6, pp. 2008–2012, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Reinecke, J. Bogdanski, A. Woltering et al., “Relation of serum levels of sex hormone binding globulin to coronary heart disease in postmenopausal women,” The American Journal of Cardiology, vol. 90, no. 4, pp. 364–368, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Mudali, A. S. Dobs, J. Ding, J. A. Cauley, M. Szklo, and S. H. Golden, “Endogenous postmenopausal hormones and serum lipids: the atherosclerosis risk in communities study,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 2, pp. 1202–1209, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. G. B. Phillips, B. H. Pinkernell, and T.-Y. Jing, “Relationship between serum sex hormones and coronary artery disease in postmenopausal women,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 17, no. 4, pp. 695–701, 1997. View at Publisher · View at Google Scholar · View at Scopus
  34. V. N. Kristensen, N. Harada, N. Yoshimura et al., “Genetic variants of CYP19 (aromatase) and breast cancer risk,” Oncogene, vol. 19, no. 10, pp. 1329–1333, 2000. View at Publisher · View at Google Scholar · View at Scopus